Miles D. White (born 1955) is an American businessman. [1] He had a 38-year career with Abbott Laboratories, most prominently being CEO between 1999 and 2020. [2] [3]
Miles D. White (born 1955) is an American businessman. [1] He had a 38-year career with Abbott Laboratories, most prominently being CEO between 1999 and 2020. [2] [3]
Miles White was born in Minneapolis, Minnesota. He went to Culver Military Academy at age 13. [4] He holds two degrees from Stanford University, a bachelor's degree in mechanical engineering and an MBA. [1] [5]
White started his career as a consultant at McKinsey & Co. [1] He joined Abbott in 1984, serving there in management positions including Senior Vice President of Diagnostic Operations and Executive Vice President. [1] He was elected to the Board of Directors in April 1998, to CEO in 1999, [6] and to Chairman of the Board in April 1999. [1] [5] As of November 2019, White's tenure is the second longest for a non-founder CEO among the S&P 100. Under his leadership, he has created approximately $200 billion in shareholder value. [7]
White has been praised for the ability to position Abbott to be able to adapt to patient and consumer needs [8] [9] and creating a diverse culture at the company. [10] He has also been praised for increasing the global stature and valuation of Abbott and expanding the company's worldwide sales. [4] [11] He has created two public companies as the CEO of Abbott: AbbVie and Hospira. [8] Hospira was later purchased by Pfizer for $16 billion. [12]
In 2017, White earned $1.9 million in base compensation and over $13.5 million in bonuses, stocks, options, and other compensation. [13] He ranked 72 in a list of highest-paid executives at S&P 500 companies for the 2017 fiscal year. [14]
In November 2019, White announced that he would be stepping down from his role as chief executive officer at Abbott on March 31, 2020, while remaining executive chairman on the company's board. [3] [15] [16] He stepped down from the board of directors in December 2021. [2]
White currently serves on the board of directors of McDonald's and Caterpillar Inc. [1] He is a former chairman of the Federal Reserve Bank of Chicago, the Economic Club of Chicago, and the Pharmaceutical Research and Manufacturers of America. [1]
He is the chairman of the board of trustees of the Culver Educational Foundation and is on the board of trustees of Northwestern University. He was also named a “Life Member” of Northwestern’s business school the Kellogg School of Management. [17] White is a fellow of the American Academy of Arts and Sciences and formerly served as chairman of the Field Museum of Natural History board of trustees. [1] [18]
White has been listed in Forbes' list of America's Most Powerful People and its America's Most Innovative Leaders. [19] [20] He was also recognized as one of the world's "30 Best CEOs" by Barron's for 11 consecutive years. [21]
In 2004, White was initiated as a member of Tau Kappa Epsilon Fraternity at Purdue University. [22]
Eric Emerson Schmidt is an American businessman and former software engineer who served as the CEO of Google from 2001 to 2011 and the company's executive chairman from 2011 to 2015. He also served as the executive chairman of parent company Alphabet Inc. from 2015 to 2017, and Technical Advisor at Alphabet from 2017 to 2020. In April 2022, the Bloomberg Billionaires Index estimated his net worth to be US$25.1 billion.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Jeffrey Robert Immelt is an American business executive currently working as a venture partner at New Enterprise Associates. He previously served as the CEO of General Electric from 2001 to 2017, and the CEO of GE's Medical Systems division from 1997 to 2000. Immelt's tenure saw GE's largest divestments in the company's history, as the company sold almost two-thirds of its subsidiaries and assets.
Ivan Seidenberg is the former chairman and CEO of Verizon Communications Inc.
Kenneth Irvine Chenault is an American business executive. He was the CEO and Chairman of American Express from 2001 until 2018. He became the third African American to serve as CEO of a Fortune 500 company.
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.
Ray R. Irani is the former chairman and chief executive officer of Occidental Petroleum. He has worked at Occidental Petroleum for over 20 years, serving as a director since 1984, chief operating officer (president) from 1984 to 1990, and chairman and chief executive officer from 1990. During his early years, he worked with Occidental CEO Armand Hammer, who at age 91, named Irani his successor in February 1990. According to Forbes.com, his five-year total compensation between 2001 and 2005 was $127,447,000. In 2006, after a rise in oil prices, Irani earned a total of $460 million.
Shantanu Narayen is an Indian-American business executive. He has been the chairman, president, and chief executive officer (CEO) of Adobe Inc. since December 2007. Before this, he was the company's president and chief operating officer since 2005.
Arthur D. Collins Jr. is an American executive, the retired chairman of the board of Medtronic, Inc., and formerly served the company as president and chief executive officer. He is now a senior advisor to Oak Hill Capital Partners and a managing partner at Acorn Advisors, LLC. Collins is also the author of the children's book series The Adventures of Archibald and Jockabeb.
William C. Weldon is a former chairman of Johnson & Johnson, He was the eighth chairman in Johnson & Johnson's history of more than one hundred years.
Stephen J. Hemsley is chair of the board and former chief executive officer of UnitedHealth Group Inc.
Jay Steven Fishman served as chairman and chief executive officer of The Travelers Companies for 11 years prior to stepping down in December 2015, following a diagnosis of ALS. He was employed as the executive chairman of the board of Travelers from December 2015 until his death in August 2016.
Virginia Marie "Ginni" Rometty is an American business executive who was executive chairman of IBM after stepping down as CEO on April 1, 2020. She was previously chairman, president and CEO of IBM, becoming the first woman to head the company. She retired from IBM on December 31, 2020, after a near-40 year career there. Before becoming president and CEO in January 2012, she first joined IBM as a systems engineer in 1981 and subsequently headed global sales, marketing, and strategy.
Michael Diekmann is a German manager who served as the CEO of Allianz in between 2003 and 2015.
Charles W. Scharf is an American investment banker and business executive who serves as the chief executive officer and president of Wells Fargo. He was previously the CEO of Visa Inc. and BNY Mellon, and has been an independent director on the Microsoft board of directors since 2014.
Donald R. Knauss is an American business executive. He is the former CEO of Clorox.
Jeffrey Leiden is an American businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
Robert B. Ford is an American businessman and the thirteenth chief executive officer at Abbott Laboratories, a publicly-traded medical devices and health care company based in Abbott Park, Illinois. He received a bachelor's degree from Boston College and an MBA in business administration from at Berkeley's Haas School of Business.
Michael Frederic Neidorff was an American business executive and was CEO of Centene Corporation from 1996 to 2022.
Albert Bourla is a American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.